Carcinoma: all 6,718 studies
Page 44 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell CarcinomaStatus unknownNCT03200691Phase 2
- Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)CompletedNCT03200587Phase 1
- Effect of DAAs on Behavior of HCC in HCV PatientsCompletedNCT03200171
- Preoperative Prediction of Microvascular Invasion in Hepatocellular CarcinomaStatus unknownNCT03198975
- An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1)CompletedNCT03198130Phase 1
- Direct-acting Antivirals and Hepatocellular Carcinoma RecurrenceCompletedNCT03197155
- Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.Status unknownNCT03196843Phase 4
- Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based ChemotherapyStatus unknownNCT03193788Phase 3
- Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT03193424Phase 2
- The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.Status unknownNCT03192644Phase 3
- The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.Status unknownNCT03192618Phase 3
- Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge TumorStatus unknownNCT03191123Not applicable
- Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell CarcinomasWithdrawnNCT03189186Phase 1
- Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive SystemStatus unknownNCT03185988Phase 2
- Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma ResponsesWithdrawnNCT03185871Phase 2
- Proton Boost for Locally Advanced HEAD AND NECK TUMORSCompletedNCT03183271Not applicable
- Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell CancerCompletedNCT03182959Early Phase 1
- Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial CarcinomaActive, not recruitingNCT03179943Phase 2
- Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric CancerStatus unknownNCT03179579Phase 3
- Combined HCC-MFCCCCompletedNCT03178409
- Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602)Status unknownNCT03177239Phase 2
- Evaluation of Pathway Modulation by Raf, MEK, & Kinase InhibitorsCompletedNCT03176485Not applicable
- Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCCStatus unknownNCT03175705Phase 1
- Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)WithdrawnNCT03172559Not applicable
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal CarcinomatosisActive, not recruitingNCT03172416Phase 1
- Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical CystectomyCompletedNCT03171493Phase 1
- QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03169764Phase 1/2
- Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine CarcinomaStatus unknownNCT03168607Phase 2
- Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine CarcinomaTerminatedNCT03168594Phase 2
- Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular CarcinomaWithdrawnNCT03168152Not applicable
- Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid CarcinomaStatus unknownNCT03167385Phase 2
- QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 TherapyWithdrawnNCT03167164Phase 1/2
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT03164382Phase 3
- Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial).CompletedNCT03163186
- Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)CompletedNCT03162198
- A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has SpreadCompletedNCT03161145
- Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP StudyWithdrawnNCT03161041Phase 2
- HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in MalawiCompletedNCT03160209
- To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid TumorsCompletedNCT03159585Phase 1
- Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)CompletedNCT03156582
- Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility StudyTerminatedNCT03150628Phase 2
- Biomarkers for Early Detection of Ovarian Cancer Using Uterine LavageStatus unknownNCT03150121Not applicable
- Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent NivolumabWithdrawnNCT03149159Phase 2
- Saliva-based Detection of CD44CompletedNCT03148665
- Phase II Study of Avelumab in Metastatic Gastronetro-pancreatic （GEP） Neuroendocrine Carcinoma （NEC, WHO Grade 3） as Second-line Treatment After Failing to Etoposide+Cisplatin: Integration of Genomic Analysis to Identify Predictive Molecular SubtypesCompletedNCT03147404Phase 2
- CAR-GPC3 T Cells in Patients With Refractory Hepatocellular CarcinomaCompletedNCT03146234Not applicable
- TATE Versus TACE in Intermediate Stage HCCTerminatedNCT03145558Phase 2
- Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical CarcinomaStatus unknownNCT03145285Phase 2
- Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell CancerCompletedNCT03144778Phase 1
- Electrochemotherapy for the Inoperable Vulva CarcinomaCompletedNCT03142061Not applicable
- Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.CompletedNCT03140332Not applicable
- Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment of the Large Hepatocellular CarcinomaStatus unknownNCT03138044Not applicable
- Percutaneous Ethanol Alcohol Injection for the Large and Unresectable Hepatocellular CarcinomaCompletedNCT03138031Not applicable
- Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon CancerTerminatedNCT03137706
- Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCCCompletedNCT03136627Phase 1/2
- Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation TherapyCompletedNCT03135782Not applicable
- A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCCompletedNCT03134872Phase 3
- Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic CarcinomaStatus unknownNCT03132740
- Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal CancerCompletedNCT03132727
- Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and NeckCompletedNCT03132038Phase 2
- A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART)Status unknownNCT03130712Phase 1/2
- Maintenance Treatment of Apatinib in Nasopharyngeal CarcinomaStatus unknownNCT03130270Phase 2
- Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular CarcinomaStatus unknownNCT03129685Not applicable
- Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT03129061Phase 1
- Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast CancerTerminatedNCT03128619Phase 1
- Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and NivolumabCompletedNCT03126331Phase 2
- A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFAStatus unknownNCT03124498Phase 1/2
- Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort StudyStatus unknownNCT03124394
- Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+Status unknownNCT03121313Phase 2
- Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHNStatus unknownNCT03117257Phase 2
- Novel Gallium Imaging in Hepatocellular CarcinomaStatus unknownNCT03116945Phase 2
- Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)WithdrawnNCT03114280Phase 1/2
- Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular CarcinomaStatus unknownNCT03114085Phase 2
- Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing SurgeryCompletedNCT03113825Phase 2
- Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial CarcinomaStatus unknownNCT03113266Phase 2
- Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersCompletedNCT03112668Not applicable
- Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell CancerWithdrawnNCT03111901Phase 1/2
- Preoperative Estimation of Microvascular Invasion in Hepatocellular CarcinomaStatus unknownNCT03110068
- Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular CarcinomaCompletedNCT03109886Phase 2
- Hepatitis C Virus Detection in Oral Squamous Cell CarcinomaCompletedNCT03109457
- NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT03109158Phase 1/2
- Assessment of QoL and Outcomes With SBRT for RCCActive, not recruitingNCT03108703Not applicable
- Register Study of Patients With Peritoneal Carcinomatosis Treated With PIPAC (Pressurized Intra-peritoneal Aerosol-Chemotherapy)Status unknownNCT03100708
- Pembrolizumab Plus Y90 Radioembolization in HCC SubjectsStatus unknownNCT03099564Early Phase 1
- A Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal CarcinomaWithdrawnNCT03096899
- A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck CancersStatus unknownNCT03096184Phase 2
- Molecular Characterization of Cutaneous TumorsStatus unknownNCT03092830
- A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer SpecimensCompletedNCT03092739
- Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung CancerCompletedNCT03091816
- Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With PazopanibCompletedNCT03091465
- Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)Approved for marketingNCT03089658
- HCC Response Assessment by MRI After SBRTCompletedNCT03088423
- Biomarker-based Study in R/M SCCHNActive, not recruitingNCT03088059Phase 2
- Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal CarcinomaStatus unknownNCT03087695
- A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLCStatus unknownNCT03085069Phase 2
- Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT03084380Phase 1/2
- BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung CancerCompletedNCT03083691Phase 2
- Risk of Hepatocellular Carcinoma in Patient With Liver CirrhosisStatus unknownNCT03083002
- Central Obesity and Hepatocellular CarcinomaStatus unknownNCT03082378
- A Study Evaluating MM-310 in Patients With Solid TumorsStatus unknownNCT03076372Phase 1